喘中的慢性炎症:超越Th2细胞的展望
Simone E M Olsthoorn1, Anneloes van Krimpen1, Rudi W Hendriks1
1Department of Pulmonary Medicine, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Immunological reviews
|February 28, 2025
概括
严重的喘涉及到比典型的T助手2细胞更复杂的免疫反应. 在难以治疗的喘病例中,二组先天性淋巴细胞和CD8+ T细胞可能会驱动类固醇耐药性炎症.
科学领域:
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
- 细胞生物学 细胞生物学
背景情况:
- 喘是一种常见的呼吸道炎症疾病,严重的,耐治疗的病例带来了重大挑战.
- 2型免疫,由CD4+T助手2 (Th2) 细胞产生IL-4,IL-5,IL-9和IL-13等细胞因子,是大多数喘的核心.
- 严重的喘机制尚不清楚,特别是在对皮质类固醇无反应的患者中.
研究的目的:
- 审查喘的病理生理学,重点关注严重的和耐治疗的形式.
- 要突出研究较少的免疫细胞的作用,包括2组先天性淋巴细胞 (ILC2s) 和2型CD8+细胞毒性T (Tc2) 细胞.
- 讨论非2型免疫在严重喘发病的参与.
主要方法:
- 关于喘病理生理学的当前科学文献的综述.
- 分析各种淋巴细胞子集在呼吸道炎症中的作用.
- 强调导致严重和抗皮质固醇喘的机制.
主要成果:
- 与Th2细胞一起,ILC2s和Tc2细胞有助于喘中的2型炎症.
- 在严重的喘中,这些替代性细胞类型可能更为普遍,并且对皮质类固醇耐药.
- 非2型免疫反应与严重的喘有关,缺乏典型的2型炎症.
结论:
- 了解严重喘中的多种免疫参与者对于开发新疗法至关重要.
- ILC2s,Tc2细胞和非2型免疫是治疗耐药喘治疗的重要标.
- 对这些替代途径的进一步研究可能会为严重喘患者提供有效的治疗方法.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management
324
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
324
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
222
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
222
Drugs Used in Lower Respiratory Disorders: Overview
334
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
334


